Page 26 - Erişkinlerde Toplumda Gelişen Pnömoniler Tanı ve Tedavi Uzlaşı Raporu

Türk Toraks Derneği Erişkinlerde Toplumda Gelişen Pnömoniler: Tanı ve Tedavi Uzlaşı Raporu

33. Öncu S, Erdem H, Pahsa A. Therapeutic options for 50. Musher DM, Thorner AR. Community-acquired pneumonia.
pneumococcal pneumonia in Turkey. Clin Ther 2005;27:674-83. N Engl J Med 2014;371:1619–1628.
34. Boz GA, Aydın K, Köksal İ, ve ark. Streptococcus pneumoniae 51. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin
ve Haemophilus influenzae suşlarının antibiyotik duyarlılığı. 7. guidance of antibiotic therapy in community- acquired
Antimikrobik Kemoterapi Günleri, Özet Kitabı, 13-15 Nisan pneumonia: a randomized trial. Am J Respir Crit Care Med
2006, Crowne Plaza / İstanbul. 2006;174:84–93.
35. Erdem H, Kiliç S, Pahsa A, Besirbellioglu. Gram-negative 52. Schuetz P, Müller B, Christ-Crain M, et al. Procalcitonin to
bacterial resistance to cephalosporins in community- acquired initiate or discontinue antibiotics in acute respiratory tract
infections in Turkey. J Chemother 2005;17:61-5. infections. Cochrane Database Syst Rev 2012;(9): CD007498.
36. Erdem H, Öncül O, Ak Ö. Pnömokok suşlarında antibakteriyel 53. Self WH, Balk RA, Grijalva CG, et al. Procalcitonin as a marker
direnç, 2002-2006 Türkiye verileri. 13 Klinik Mikrobiyoloji of etiology in adults hospitalized with community-acquired
ve İnfeksiyon Hastalıkları Kongresi, P-275; 14-18 Mart 2007, pneumonia. Clin Infect Dis 2017;65:183–190.
Belek Antalya. 54. Lim WS, van der Eerden MM, Laing R, et al. Defining
37. Bates JH, Campbell GD, Barron AL, et al. Microbial etiology community acquired pneumonia severity on presentation
of acute pneumonia in hospitalized patients. Chest 1992; to hospital: an international derivation and validation study.
101:1005-12. Thorax 2003;58:377-82.
38. Fang GD, Fine M, Orloff J, et al. New and emerging etiolo- gies 55. Zhang ZX, Yong Y, Tan WC, et al. Prognostic factors for
for community-acquired pneumonia with implications for mortality due to pneumonia among adults from different age
therapy; a prospective multicenter study of 359 cases. Medicine groups in Singapore and mortality predictions based on PSI
(Balt) 1990;69:307-16. and CURB-65. Singapore Med J. 2018 Apr;59(4):190-198. doi:
39. MacFarlane JT, Miller AC, Smith WHR, et al. Comparative 10.11622/smedj.2017079. Epub 2017 Aug 14. PMID: 28805234;
radiographic features of community-acquired Legionnaires’ PMCID: PMC5915635.
disease, pneumococcal pneumonia, mycoplasma pneumonia 56. Chalmers JD, Taylor JK, Singanayagam A, Fleming GB,
and psittacosis. Thorax 1984;39:28-33. Akram AR, Mandal P, Choudhury G, Hill AT. Epidemiology,
40. Işık S. Akciğer infeksiyonları radyolojisi. In: Numanoğlu N, antibiotic therapy, and clinical outcomes in health care-
Willke A, ed. Güncel Bilgiler Işığında Pnömoniler. Ankara: associated pneumonia: a UK cohort study. Clin Infect Dis 2011
Bilimsel Tıp Yayınevi, 2000:129-72. Jul 15;53(2):107-13
41. Alper H. İmmünsupressif hastalarda akciğer patolojilerinin 57. Kett DH, Cano E, Quartin AA, Mangino JE, Zervos MJ,
radyolojisi. In: Uçan ES, ed. Pnömoniler: Bir Devin Uyanışı. Peyrani P, Cely CM, Ford KD, Scerpella EG, Ramirez JA;
İzmir: Saray Tıp Kitabevi, 1996;243-58. Improving Medicine through Pathway Assessment of Critical
42. Janssen RS, Louis ME, Satten GA, et al. HIV infection among Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP)
Investigators. Implementation of guidelines for management
patients in US acute-care hospitals. N Engl J Med 1992; 327:445- of possible multidrug-resistant pneumonia in intensive care: an
52. observational, multicentre cohort study. Lancet Infect Dis 2011
43. Stratton CW. Utilization of blood cultures in the 21st cen- tury. Mar;11(3):181-9
Antimicrob Infect Dis Newslett 2000;18:9-12. 58. Attridge RT, Frei CR, Restrepo MI, Lawson KA, Ryan L, Pugh
44. Leblebicioğlu H. Atipik pnömoniler. İnfeks Bül 1996;1:153-8. MJ, Anzueto A, Mortensen EM. Guideline-concordant therapy
45. Eraksoy H. Toplumda gelişen pnömoniler: tedavi. In: and outcomes in healthcare-associated pneumonia. Eur Respir
Numanoğlu N, Willke A, ed. Güncel Bilgiler Işığında J 2011; 38(4):878-87
Pnömoniler. Ankara: Bilimsel Tıp Yayınevi, 2000:24-48. 59. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and
46. Cunha BA. The atypical pneumonias: clinical diagnosis and treatment of adults with community-acquired pneumonia. An
importance. Clin Microbiol Infect 2006; 12 Suppl 3: 12-24. official clinical practice guideline of the American Thoracic
47. Blot SI, Rodriguez A, Solé-Violán J, et al. Effects of delayed Society and Infectious Diseases Society of America. Am J Respir
oxygenation assessment on time to antibiotic delivery and Crit Care Med 2019; 200: e45-e67.
mortality in patients with severe community-acquired pne- 60. Öksüz L, Gürler N. Bir Üniversite Hastanesinde Yetişkin
umonia. Crit Care Med 2007;35:2509-14. Hastalardan İzole Edilen Streptococcus pneumoniae Suşlarının
48. Dhingra R, Gona P, Nam BH, et al. C-reactive protein, Serotip Dağılımı ve Antibiyotik Direnci. Mikrobiyol Bul 2017;
inflammatory conditions, and cardiovascular disease risk. Am J 51:195-208.
Med. 2007;120(12):1054-62. 61. Söyletir G, Altınkanat G, Gür D ve ark. Results from the
49. Kushner I. C-reactive protein elevation can be caused by Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey. J
conditions other than inflammation and may reflect biologic Antimcirob Chemother 2016; 71(Suppl 1): i71-i83.
aging. Cleve Clin J Med. 2001;68(6):535-7, http://dx.doi.
org/10.3949/ccjm.68.6.535.

18